You can find more information about 3',5'-cyclic-GMP phosphodiesterase using the following links:

PFID

PFID Old

Formal Annotation

PlasmoDB

TDR Targets

Subcellular Localization

Affecting Drugs

Drug Name

PubMed Articles (year of publication)

PF3D7_1209500

PFL0475w

cGMP-specific 3',5'-cyclic phosphodiesterase alpha

Adenosine cyclic 3',5'-monophosphate derivatives	Cyclic AMP and calcium interplay as second messengers in melatonin-dependent regulation of Plasmodium falciparum cell cycle
E64	Active site similarity between human and Plasmodium falciparum phosphodiesterases: considerations for antimalarial drug design
Ibmx	PfPDE1, a novel cGMP-specific phosphodiesterase from the human malaria parasite Plasmodium falciparum
Sildenafil	Active site similarity between human and Plasmodium falciparum phosphodiesterases: considerations for antimalarial drug design
Tadalafil	Drug to genome to drug: discovery of new antiplasmodial compounds
Theophylline	PfPDE1, a novel cGMP-specific phosphodiesterase from the human malaria parasite Plasmodium falciparum
Yanangcorinine	PfPDE1, a novel cGMP-specific phosphodiesterase from the human malaria parasite Plasmodium falciparum
Zaprinast	PfPDE1, a novel cGMP-specific phosphodiesterase from the human malaria parasite Plasmodium falciparum Active site similarity between human and Plasmodium falciparum phosphodiesterases: considerations for antimalarial drug design

PF3D7_1321600

MAL13P1.119

cGMP-specific 3',5'-cyclic phosphodiesterase gamma, putative

Tadalafil

PF3D7_1470500

PF14_0672

cgmp-specific 3',5'-cyclic phosphodiesterase delta, putative

Tadalafil